Triethylamine → HCID 178481068, compound
Reaction equation
[F:1][C:2]([F:24])([F:23])[C:3]1[CH:8]=[CH:7][C:6]([S:9]([NH:12][CH2:13][C@H:14]2[CH2:19][CH2:18][C@H:17]([C:20]([OH:22])=O)[CH2:16][CH2:15]2)(=[O:11])=[O:10])=[CH:5][CH:4]=1.CCN=C=NCCCN(C)C.CCN(CC)CC.[CH3:43][N:44]1[CH2:49][CH2:48][NH:47][CH2:46][CH2:45]1>C(Cl)Cl.O>[CH3:43][N:44]1[CH2:49][CH2:48][N:47]([C:20]([C@H:17]2[CH2:16][CH2:15][C@H:14]([CH2:13][NH:12][S:9]([C:6]3[CH:7]=[CH:8][C:3]([C:2]([F:23])([F:1])[F:24])=[CH:4][CH:5]=3)(=[O:10])=[O:11])[CH2:19][CH2:18]2)=[O:22])[CH2:46][CH2:45]1Participants
Procedure
200 mg (0.54 mmol) of trans-4-[(4-trifluoromethyl-benzenesulfonylamino)-methyl]-cyclohexanecarboxylic acid, 210 mg (1.09 mmol, 2 eq) of EDCI, 221 mg (2.2 mmol, 4 eq) of Et3N and 274 mg (2.74 mmol, 5 eq) of 1-methyl-piperazine were dissolved in 5 mL of CH2Cl2. After 70 h reaction at RT, 1 mL of H2O was added and the reaction mixture was stirred vigorously for 1 h. The organic phase was separated, the aqueous phase was extracted with 10 mL of CH2Cl2 and the combined organic phases were washed with H2O and brine. After drying over anhydrous Na2SO4, the organic phase was evaporated. The residue was chromatographed on silicagel with CH2Cl2:MeOH:25% NH4OH (9:1:0.1) as eluent. 120 mg (49%) of trans-N-[4-(4-methyl-piperazine-1-carbonyl)-cyclohexylmethyl]-4-trifluoromethyl-benzenesulfonamide were obtained as colorless amorphous solid, MS: 448 (MH+).
Workup
- customAfter 70 h reaction at RT
- customThe organic phase was separated
- extractionthe aqueous phase was extracted with 10 mL of CH2Cl2
- washthe combined organic phases were washed with H2O and brine
- dry with materialAfter drying over anhydrous Na2SO4
- customthe organic phase was evaporated
- customThe residue was chromatographed on silicagel with CH2Cl2
Sources & evidence
- ORD record
- ord-6f00382d8b2043f5902398176a5f0bf1
- Source dataset
- uspto-grants-2008_10
- Patent number
- US07442791B2
Reaction notes
Loading…